Condition
Left Ventricular Thrombus clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Left Ventricular Thrombus clinical trials that are recruiting, at sites in 6 countries (most in United Kingdom (1), Nepal (1), United States (1)). By phase: Phase 4 (2), Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Left Ventricular Thrombus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Apixaban vs Warfarin for a Left Ventricular Thrombus | Phase 3 | Tucson, Arizona | Recruiting | Jul 17, 2026 |
| Registry for patients with left ventricular thrombus | — | Cambridge, Cambridgeshire and 7 other locations | Recruiting | May 9, 2025 |
| Using Apixaban to prevent blood clots after heart attacks | Phase 3 | Karachi, Sindh | Recruiting | Dec 19, 2024 |
| Apixaban versus warfarin for left ventricular clot after a heart attack | Phase 4 | Falun and 15 other locations | Recruiting | Jul 23, 2024 |
| Anticoagulation After a Heart Attack with Left Ventricular Clot | — | Changchun, Jilin | Recruiting | Jun 7, 2023 |
| Comparing anticoagulants for treating left ventricular thrombus after heart attacks in Nepal | Phase 4 | Kathmandu, Bagmati | Recruiting | Apr 3, 2023 |
All recruiting trials (6)
-
Apixaban vs Warfarin for a Left Ventricular Thrombus
This study tests whether apixaban can more conveniently and safely dissolve a left ventricular blood clot compared with warfarin.
-
Registry for patients with left ventricular thrombus
This study is gathering information from people with blood clots in the heart to better understand the condition and improve treatment options.
-
Using Apixaban to prevent blood clots after heart attacks
This study is testing if a low dose of Apixaban can help prevent blood clots in people who have had a heart attack and have weak heart function.
-
Apixaban versus warfarin for left ventricular clot after a heart attack
This compares apixaban and warfarin to see which better clears left-ventricular blood clots in adults after a heart attack.
-
Anticoagulation After a Heart Attack with Left Ventricular Clot
This study tests whether adding rivaroxaban to standard dual antiplatelet therapy helps people who develop a left ventricular thrombus after a STEMI.
-
Comparing anticoagulants for treating left ventricular thrombus after heart attacks in Nepal
This study is testing whether two blood-thinning medications, Rivaroxaban and Warfarin, can help people in Nepal with blood clots in the heart after a heart attack.
Related topics
Quick answers
How many Left Ventricular Thrombus clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United Kingdom (1 trial), Nepal (1 trial), United States (1 trial), Sweden (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.